Home
Prevention

Treatment
Other Addictions
Opiate Addiction-Treatment
Faith Based
Advocacy-Recovery
About Us
Contact Us

Kentucky OAR

Faith Based

This page provides information that is specific to opiate abuse and addiction. Opiates include drugs such as Heroin, Oxycontin, Lortab, Vicodin, and Percoset.
Majority of the information provided here focuses on Medication Assisted Treatment for opiate addiction, which includes Methadone and Suboxone.
You will find information about how to locate treatment, advocacy and support groups that are available, educational information, resources for professionals in the addictions field, and regulations/guidelines that are all specific to opiate addiction and treatment.

INTERNET RESOURCES FOR
MEDICATION ASSISTED TREATMENT FOR OPIATE ADDICTION

Locating Treatment

http://dpt2.samhsa.gov/treatment/
This is the Substance Abuse and Mental Health Services Administration’s (SAMHSA) page for locating both public and private opiate addiction treatment programs across the country.

http://buprenorphine.samhsa.gov/bwns_locator/
SAMHSA’s page for locating providers across the country who are certified to provide treatment with Buprenorphine.

http://www.naabt.org/patient_dr_connection.cfm
This is the National Alliance of Advocates for Buprenorphine Treatment’s (NAABT) page for locating providers across the country who are certified to provide treatment with Buprenorphine. (Please keep in mind that not all providers listed on SAMHSA’s locator above are listed here and physicians are not required to list themselves on either treatment locator page).

If you are interested in locating other types of licensed drug and alcohol treatment programs in Kentucky, then please click here.

Advocacy and Support

http://www.methadone.org/
The National Alliance of Methadone Advocates (NAMA) is an organization composed of methadone patients and health care professionals that are supporters of quality opiate agonist treatment. The primary objective of NAMA is to advocate for the patient in treatment by de-stigmatizing and empowering methadone patients.

http://www.naabt.org/
The National Alliance of Advocates for Buprenorphine Treatment (NAABT) is a non-profit organization with the mission to educate the public about the disease of opioid addiction and the buprenorphine treatment option, to help reduce the stigma and discrimination associated with patients with addiction disorders, and serve as a channel connecting patients in need of treatment to qualified treatment providers. 

http://www.methadonesupport.org/
This is the official site of the Methadone Anonymous (MA) community.  It is the purpose of this fellowship to learn to develop a positive lifestyle, live in harmony with ourselves and the rest of the world and to help those of us who still suffer from chemical dependency of any kind to achieve and maintain sobriety.

http://www.afirmfwc.org/
The Advocates for the Integration of Recovery and Methadone (AFIRM) began as a grass roots patient and health provider advocacy organization and continues today to focus on the basic needs and rights of both groups.

Educational and Professional

http://www.atforum.com/SiteRoot/pages/addiction_resources/MMT_book_2006.pdf
This 125-page book from Santa Clara Valley Health & Hospital System, San Jose, CA, covers all the basics for clinic staff, patients, community leaders, criminal justice system authorities, and interested others.

http://www.medicalassistedtreatment.org/4436/index.html
This is the website of the Georgia-based nonprofit corporation, Medical Assisted Treatment of America, that provides education, support, and current news as related to opiate addiction and opiate agonist treatment.

http://www.suboxoneassistedtreatment.org/index.html
This organization is a subsidiary of Medical Assisted Treatment of America and focuses specifically on education and advocacy about the medication Suboxone.

http://www.suboxone.com/
This is the official site for the medication Suboxone, providing information on how this medication works, the treatment process, and client stories.

http://dpt.samhsa.gov/ 
The Center for Substance Abuse Treatment's Division of Pharmacologic Therapies (DPT) manages the day-to-day regulatory oversight activities necessary to implement new SAMHSA regulations (42 CFR Part 8) on the use of Opioid agonist medications (methadone, LAAM, and Buprenorphine) approved by the Food and Drug Administration (FDA) for addiction treatment..
DPT also supports the training of medical and substance abuse professionals on a variety of treatment issues, including the use of new medications that are anticipated to be approved by the FDA for use by physicians.

http://www.aatod.org/
The American Association for the Treatment of Opioid Dependence (AATOD) was founded in 1984 to enhance the quality of patient care in treatment programs by promoting the growth and development of comprehensive methadone treatment services throughout the United States.  

http://www.atforum.com/
This website features extensive resources, such as: current and past issues of Addiction Treatment Forum newsletters, special research reports, regularly updated news, and much more.  Although many treatment options and healthcare topics of concern are regularly discussed, an important focus is on methadone maintenance for opioid-addiction treatment.

Regulations, Standards, and Guidelines

http://www.lrc.ky.gov/kar/908/001/340.htm
This is a direct link to the Kentucky State Regulations for Opioid Treatment Programs.  These are the regulations that all opiate treatment programs must follow in order to open and operate.

http://www.access.gpo.gov/nara/cfr/waisidx_05/42cfr8_05.html
This is a direct link to the Federal Regulations for Opioid Treatment Programs.  These are the regulations that all opiate treatment programs must follow in order to open and operate.

http://www.deadiversion.usdoj.gov/pubs/manuals/narcotic/index.html
This guideline is provided by The Drug Enforcement Administration (DEA) to assist in the understanding of the provisions of the Controlled Substances Act of 1970 (CSA) and in the implementation of the regulations as they apply to dosage reconciliation practices in opioid treatment programs. These guidelines should answer many of the questions that treatment programs have and should provide guidance to assist programs in complying with the regulations.

 


Home | About Us | Contact Us
© 2008 Kentucky OAR